Search research articles
Contact Us
Filters
Showing results (681-690 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
JAMA Oncology
|
March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
European Urology
|
October 30, 2025
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry
Madeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, et al.
European Urology
|
July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial
Loïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor
Rainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Valentina Ambrosini, Jolanta Kunikowska, Eric Baudin, et al.
Signal Transduction and Targeted Therapy
|
September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
Claire M Storey, Mohamed Altai, Katharina Lückerath, et al.
Page
of 73
Search research articles
Search
Showing results (681-690 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
JAMA Oncology
|
March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
European Urology
|
October 30, 2025
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry
Madeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, et al.
European Urology
|
July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial
Loïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor
Rainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Valentina Ambrosini, Jolanta Kunikowska, Eric Baudin, et al.
Signal Transduction and Targeted Therapy
|
September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
Claire M Storey, Mohamed Altai, Katharina Lückerath, et al.
Page
of 73